FDA Approved: SYMBRAVO — Original Application (Axsome Therapeutics, Inc.)

View source ↗

Summary

FDA approved SYMBRAVO, a fixed-dose combination of meloxicam and rizatriptan from Axsome Therapeutics, under an original NDA for the acute treatment of migraine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• SYMBRAVO (meloxicam; rizatriptan)

Snippet

ORIG AP for SYMBRAVO (MELOXICAM, RIZATRIPTAN)